TAMPA, Fla., May 11, 2015 /PRNewswire/ -- Advanzeon
Solutions, Inc. (OTCBB: CHCR), ("Advanzeon" or the "Company") is
pleased to announce that James L.
Koenig has been appointed to serve on the Company's Board of
Directors, effective immediately. Mr. Koenig has functioned
as the Company's Acting Chief Financial Officer since December,
2013.
"We actively recruited Mr. Koenig to accept a director's
position on the Board because of his background, prudence and
desire to assist the Company to achieve its immediate goal to
provide the value promised to our customers and shareholders," said
Dr. Mark Heidt, President and
Director of Advanzeon Solutions, Inc..
"I am excited and honored to join the Company's Board of
Directors. I believe this appointment allows me the platform
to continue moving the Company forward to its next level of
success," said Mr. Koenig. "I have seen, first hand, the
potential of Advanzeon and its subsidiary, Pharmacy Value
Management Solutions, Inc., and I am confident that the Company is
absolutely poised to achieve its full financial potential."
Prior to joining the Company, Mr. Koenig was Senior Vice
President and Chief Financial Officer of The Amacore Group from
1994 to 2007; Director of Regulatory Affairs and other executive
positions for TECO Energy, Inc. from 1984 to 1994; and, various
positions, the most recent being Assistant Comptroller for Duke
Energy from 1970 to 1984. He received his Bachelors in
Accounting from Indiana State
University.
About Advanzeon Solutions, Inc.
Established in 1969,
Advanzeon provides behavioral health, substance abuse and pharmacy
management services, as well as sleep apnea programs, for
employers, Taft-Hartley health and welfare Funds, and managed care
companies throughout the United States. Headquartered in
Tampa, Florida, the Company
focuses on personalized attention, flexibility, a commitment to
high-quality services and innovative approaches that address both
the specific needs of clients and changing healthcare industry
demands. For more information, please call 813-367-9080 or
visit our website at www.advanzeon.com.
Forward-Looking Statements
Except for statements of
historical fact, the matters discussed in this press release are
forward looking and made pursuant to the Safe Harbor provisions of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements reflect the current beliefs and
expectations of the Company's management, reflect numerous
assumptions, and are subject to significant risks and
uncertainties, many of which are beyond the Company's
control. If any of these underlying beliefs, expectations or
assumptions prove inaccurate or risks or uncertainties materialize,
actual results may differ materially from those set forth in the
forward-looking statements.
These risk factors include, among others, the ability of the
Company to maximize its market share with new pharmacy initiatives,
the ability of the Company's new pharmacy cost-savings program to
guarantee a 10% or more reduction in pharmacy costs, our ability to
achieve expected results from new business and to revolutionize the
pharmacy sector of the healthcare industry, the ability to obtain a
performance bond on satisfactory terms, the ability of the
Company's pharmacy program to promote greater medication adherence
without restricting access to needed medications, technological
advances, challenges in development of new products and services,
new products and services developed by competitors, the Company's
ability to provide superior patient care while increasing its
business and margins as a result of implementing its pharmacy
cost-savings program, general industry conditions and competition,
general economic factors, global trends toward health care cost
containment, the effect of governmental regulation, including
pharmaceutical industry regulation, insurance regulation and health
care legislation, varying trends in member pharmacy utilization,
increases or variations in cost of care, seasonality, our ability
to manage healthcare operating expenses, the profitability (if any)
from capitated pharmacy contracts or other products, and the
Company's ability to obtain additional financing.
Advanzeon undertakes no obligation to publicly update or
revise any forward-looking statement, whether as a result of new
information, future events or otherwise. Additional risk
factors that could cause results to differ materially from
those described in the forward-looking statements can be found in
the Company's most recent Annual Report on Form 10-K and the
Company's other filings with the Securities and Exchange Commission
(SEC), which are available at the SEC's website at
www.sec.gov.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/advanzeon-solutions-inc-announces-the-appointment-of-james-l-koenig-to-its-board-of-directors-300080949.html
SOURCE Advanzeon Solutions, Inc.